The thesis: China's low-cost robotics champion
Unitree Robotics is the clearest embodiment of a distinctly Chinese answer to the humanoid-robot race: rather than chase a single, expensive, general-purpose machine, it floods the market with a ladder of legged robots priced far below Western peers and lets scale, iteration speed, and a deep domestic supply chain do the rest. That playbook took Unitree from a niche maker of research quadrupeds to the world's top-selling humanoid company by volume in 2025, with more than 5,500 humanoids shipped and a roughly 32% global share by unit count.
What makes Unitree unusual among high-profile robot companies is that it is already profitable. Its Shanghai listing prospectus reports about 1.71 billion yuan (~$250 million) of 2025 revenue and adjusted net profit near 590–600 million yuan at a 60% gross margin — figures most humanoid startups, still years from meaningful revenue, cannot approach. The company matters because it reframes the humanoid question from 'can it be built?' to 'how cheaply can it be sold, and how fast?' — a framing that pressures every competitor's pricing and timeline.
From a $200 college robot to Hangzhou's robot maker
Unitree is inseparable from its founder, Wang Xingxing, born in 1990 in Ningbo. As a first-year mechatronics student at Zhejiang Sci-Tech University he built a small bipedal robot from roughly 200 yuan of parts, and during a mechanical-engineering master's at Shanghai University he developed XDog, a low-cost, fully articulated quadruped driven by inexpensive outer-rotor brushless motors. The XDog demos went viral and drew both buyers and investors, convincing Wang there was a real market for affordable legged robots.
He briefly worked at drone giant DJI before resigning to register Hangzhou Unitree Technology in August 2016. The early bet — that dynamic legged robots could be a consumer and research product rather than a six-figure laboratory curiosity — set the company's entire trajectory. Backed early by Sequoia Capital China, Unitree spent its first years building a leading position in publicly sold quadrupeds, shipping more than 30,000 of them between 2022 and September 2025 before humanoids became its center of gravity.
The product ladder: quadrupeds to humanoids
Unitree's catalog is a deliberate price-and-capability ladder. On the quadruped side it spans the ~$1,600 Go2 consumer dog, the industrial B2, and the rugged A2 'Stellar Hunter' built for inspection and logistics with a 100 kg standing load and dual front-and-rear LiDAR. On the humanoid side it runs from the ~$4,900 R1 lightweight developer robot, through the ~$13,500 G1 research avatar, up to the full-size H1 and the second-generation H2, which adds a bionic head, more onboard compute, and longer endurance at a ~$29,900 starting price.
The through-line is aggressive cost engineering: Unitree designs its own motors, joints, and sensors, letting it undercut rivals by an order of magnitude and put capable hardware in the hands of universities, developers, and hobbyists. That accessibility has made Unitree robots a default research platform worldwide — more than 70% of its 2025 humanoid units went to research and education — and turned viral moments (16 H1 robots dancing at China's Spring Festival Gala, staged G1 'robot combat' events) into a marketing flywheel few competitors can match.
The low-cost playbook and its margin cost
The same strategy that wins volume is now squeezing profitability. Average humanoid selling prices collapsed from about 593,400 yuan in 2023 to roughly 167,600 yuan in 2025 as Unitree and a swarm of Chinese rivals cut prices to grab share. The effect showed up starkly in early 2026: Q1 revenue rose about 68% year over year to RMB 422.8 million, but adjusted net profit fell roughly 52% to RMB 40.3 million, a reminder that Unitree is fighting a price war it partly started.
Unitree's prospectus guides H1 2026 revenue to RMB 1.05–1.13 billion and adjusted net profit to RMB 236–283 million, implying a sequential margin recovery from the Q1 trough. The durable moat, if there is one, is vertical integration and manufacturing scale — owning the components and driving unit costs down faster than competitors — plus a broadening move from finished robots into embodied-AI models, dexterous hands, arms, and sensors that could turn Unitree into a supplier to the wider robotics industry rather than only a robot brand.
First profits, a record IPO, and Nvidia's endorsement
Unitree's funding history runs from an undisclosed 2018 Sequoia Series A through a February 2024 Series B2 of nearly $139 million led by Meituan, to a June 2025 Series C — backed by China Mobile's fund, Tencent, Alibaba, Ant Group, Geely, and HongShan — that valued the company around $1.7 billion. It is now completing that arc in public markets: on July 2–3, 2026 Unitree secured CSRC registration approval for a Shanghai STAR Market IPO, clearing the full review in a record ~104 days and putting it on track to be the first listed Chinese humanoid-robot maker.
The offering targets about 4.2 billion yuan (~$618 million) by selling at least 40.4 million shares — a minimum 10% stake implying a valuation near 42 billion yuan (~$6 billion) — with proceeds earmarked for robot-model and robot-body R&D, new products, and a dedicated smart-manufacturing base. Validation also arrived on the technology side: at COMPUTEX in June 2026, Nvidia unveiled its Isaac GR00T reference humanoid built on Unitree's H2 body, Sharpa's 25-DoF hands, and Nvidia's Blackwell-class compute, making Unitree Nvidia's reference humanoid hardware partner.
What to watch: scaling, the Pentagon listing, and the price war
The nearest catalyst is the IPO itself. As of mid-July 2026 the issuance had cleared registration but not yet priced or begun trading; a final share price and subscription date remained unset, with a debut possible as early as late July or August. How that listing prices will be an early public test of whether investor enthusiasm for embodied AI can support a multi-billion-dollar valuation on a company whose profits just dipped.
The operational test is manufacturing. Unitree aims to ship roughly 20,000 humanoids in 2026 — nearly quadruple 2025 — and has floated a five-year goal of 75,000 humanoids and 115,000 quadrupeds a year, a leap that requires replacing largely manual, outsourced assembly with flexible mass production. The wildcard is geopolitics: the Pentagon's June 2026 Section 1260H designation, which groups Unitree with Alibaba, Baidu, and BYD as alleged supporters of China's military-civil fusion, restricts direct U.S. Defense Department contracting from June 30, 2026 and indirect procurement a year later — a threat to the U.S. research-lab customer base that has been central to Unitree's global footprint, even as its home and non-U.S. markets stay open.
Sources
- Caixin Global — Unitree wins approval for $618M STAR Market IPO
- Rest of World — China robot maker Unitree files for Shanghai IPO
- CNBC — Nvidia unveils Isaac GR00T humanoid on Unitree's H2 body
- SCMP — Unitree reports plunge in Q1 profits ahead of IPO hearing
- TechCrunch — Pentagon Section 1260H designation
- Wikipedia — Wang Xingxing (founder background)
- eWeek — Unitree targets 20,000 humanoid robots in 2026